Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

CHC: Passage of President Obama's health care reform proposal would improve quality of life for Latinos

The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.

19 Mar 2010

Kaiser Permanente study: Snapshot of the prevalence of extreme obesity in younger children

Extreme obesity is affecting more children at younger ages, with 12 percent of black teenage girls, 11.2 percent of Hispanic teenage boys, 7.3 percent of boys and 5.5 percent of girls now classified as extremely obese, according to a Kaiser Permanente study of 710,949 children and teens that appears online in the Journal of Pediatrics.

19 Mar 2010

U.S.-based CRO licenses NewCardio's QTinno software solution for automating cardiac safety analysis

NewCardio, Inc., a cardiac diagnostic technology provider, announced today that a U.S.-based CRO that provides early phase and specialty clinical drug development services to the pharmaceutical industry, has signed an MSA, licensing NewCardio's QTinno™ software solution in order to deliver fully automated cardiac safety analysis in early phase QT studies.

18 Mar 2010

Bailout stenting successful treatment for infants with constricted aortas

Cardiac interventionalists and surgeons at University Clinic in Leuven, Belgium have achieved successful stent implantation and follow-up coarctectomy in premature infants suffering from aortic coarctation. Full findings are published in the March issue of Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.

18 Mar 2010

USPTO allows Regulus Therapeutics' claims covering methods of antagonizing miR-181a for regulating immune response

Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.

18 Mar 2010

New book exposes the ignored causes of three major life-threatening and chronic diseases

In his newest book, "Overlooked Causes and the Prevention: Cancer, Cardiovascular Heart Disease, Multiple Sclerosis" (published by AuthorHouse), author Arthur Douglass Alexander III exposes, delineates and documents the sometimes overlooked and often ignored causes of three major life-threatening and chronic diseases: cancer, cardiovascular disease and multiple sclerosis.

18 Mar 2010

Loneliness can raise blood pressure

Chronic feelings of loneliness take a toll on blood pressure over time, causing a marked increase after four years, according to a new study at the University of Chicago.

18 Mar 2010

Berkeley HeartLab adopts GenTegra DNA to support diagnostic genetic testing for cardiovascular disease

GenVault Corporation today announced that Berkeley HeartLab, a subsidiary of Celera Corporation, has adopted GenTegra DNA to preserve and store diagnostic samples for genetic testing related to the management of cardiovascular disease.

18 Mar 2010

AstraZeneca's CRESTOR: Health Canada approves new indication

AstraZeneca announced today that Health Canada has approved CRESTOR (rosuvastatin calcium) to reduce the risk of nonfatal myocardial infarction (heart attack), nonfatal stroke, and coronary artery revascularization in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.

17 Mar 2010

TRITON-TIMI 38 study evaluates response rates in patients with common genetic variant in ABCB1 gene

A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the ABCB1 gene. Patients enrolled in the TRITON-TIMI 38 study were treated with dual antiplatelet therapy with either Plavix® (clopidogrel) plus aspirin or Effient® (prasugrel) plus aspirin and managed with percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS) event.

17 Mar 2010

Research data: WTC collapse caused potentially dangerous heart problems in responders on-site

Researchers from Mount Sinai School of Medicine are presenting more than 20 ground-breaking studies at the American College of Cardiology 59th annual scientific session (ACC.10) in Atlanta. Their research includes data showing that the World Trade Center collapse has caused potentially dangerous heart problems in responders on-site.

17 Mar 2010

TomTec's multi-modality cardiovascular image analysis technology to be delivered as part of Kardia Complete

Kardia Health Systems and TomTec Imaging Systems today announced a new partnership to deliver TomTec's multi-modality cardiovascular image analysis technology as a part of Kardia Complete™, Kardia's forthcoming Web-based service to simplify workflow and save time in cardiology practices.

17 Mar 2010

Obese patients face lower risk of sudden cardiac death compared to non-obese patients

Obesity has long been identified as a risk factor for cardiovascular disease and heart failure. But, a new study conducted by researchers at the University of Rochester Medical Center found that being skinny confers no advantage when it comes to the risk of dying suddenly from cardiac causes.

17 Mar 2010

Medtronic launches Every Patient First health equity initiative.

Medtronic, Inc. today introduced Every Patient First, a health equity initiative that, in partnership with health care providers, professional societies and patient advocacy groups, aims to reduce disparities in access to health care in the United States. The announcement was made at the 59th Annual Scientific Session of the American College of Cardiology in Atlanta.

17 Mar 2010

Pfizer-FRSQ-MSSS Chronic Disease Fund for chronic-disease prevention and management initiatives

The Fonds de la recherche en santé du Québec in partnership with the Ministère de la Santé et des Services sociaux and Pfizer Canada, is announcing the creation of the Pfizer-FRSQ-MSSS Chronic Disease Fund. Established with an investment of $5 million from Pfizer Canada, this research grant program, coordinated by the FRSQ, is open to Quebec-based researchers who work in collaboration with health professionals.

17 Mar 2010

Viron Therapeutics' VT-346 anti-TNF protein exhibits positive results in transgenic mouse model for arthritis

Viron Therapeutics Inc. announced that VT-346, an anti-TNF protein therapeutic, demonstrated positive results in a pivotal proof of concept study in the gold standard transgenic mouse model for arthritis. VT-346 achieved a statistically significant, dose dependent impact in this preclinical model of arthritis and prevented deterioration due to disease in terms of weight gain, arthritic score and pathology parameters. VT-346 had particularly strong protective effects on therapeutically-important bone and cartilage damage in this model.

16 Mar 2010

Childhood stress and trauma may accelerate cellular aging

Children who suffer physical or emotional abuse could be faced with accelerated cellular aging as adults, according to new research published by Elsevier in Biological Psychiatry.

16 Mar 2010

Tips for reducing LDL cholesterol

Cardiovascular disease is the No.1 killer in North America. And high cholesterol is one of the primary risk factors of coronary heart disease and stroke. According to the Heart and Stroke Foundation, almost 40% of Canadian adults are classified as having high blood cholesterol levels.

16 Mar 2010

Meditation and walking can help lower BP and heart rate

Simple, low-cost measures such as wearing a pedometer to inspire walking and spending a few minutes a day meditating can put adolescents on the track toward better health, researchers report.

16 Mar 2010

MAQUET's VASOVIEW EVH reduces rates of leg infection in CABG patients

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that study results published in the January 2010 Annals of Thoracic Surgery demonstrated that coronary artery bypass graft (CABG) patients who undergo Endoscopic Vessel Harvesting (EVH) demonstrate similar long-term clinical outcomes as patients who undergo traditional "open" vein harvest (OVH) but have significantly reduced rates of leg infection.

16 Mar 2010

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

CHC: Passage of President Obama's health care reform proposal would improve quality of life for Latinos

Kaiser Permanente study: Snapshot of the prevalence of extreme obesity in younger children

U.S.-based CRO licenses NewCardio's QTinno software solution for automating cardiac safety analysis

Bailout stenting successful treatment for infants with constricted aortas

USPTO allows Regulus Therapeutics' claims covering methods of antagonizing miR-181a for regulating immune response

New book exposes the ignored causes of three major life-threatening and chronic diseases

Loneliness can raise blood pressure

Berkeley HeartLab adopts GenTegra DNA to support diagnostic genetic testing for cardiovascular disease

AstraZeneca's CRESTOR: Health Canada approves new indication

TRITON-TIMI 38 study evaluates response rates in patients with common genetic variant in ABCB1 gene

Research data: WTC collapse caused potentially dangerous heart problems in responders on-site

TomTec's multi-modality cardiovascular image analysis technology to be delivered as part of Kardia Complete

Obese patients face lower risk of sudden cardiac death compared to non-obese patients

Medtronic launches Every Patient First health equity initiative.

Pfizer-FRSQ-MSSS Chronic Disease Fund for chronic-disease prevention and management initiatives

Viron Therapeutics' VT-346 anti-TNF protein exhibits positive results in transgenic mouse model for arthritis

Childhood stress and trauma may accelerate cellular aging

Tips for reducing LDL cholesterol

Meditation and walking can help lower BP and heart rate

MAQUET's VASOVIEW EVH reduces rates of leg infection in CABG patients

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in